Heat Therapy in Older Hypertensive Women
Launched by UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER · Feb 25, 2019
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of heat therapy on lowering blood pressure in older women with high blood pressure, known as hypertension. Researchers want to find out if soaking the lower legs in warm water can help reduce blood pressure even more effectively when combined with standard blood pressure medications. The trial will involve women aged 65 to 85 who have mild to moderate hypertension. Participants will be divided into two groups: one will receive heat therapy, while the other will immerse their legs in cool water for comparison.
To be eligible for this study, women must have a specific range of blood pressure and be able to understand and speak English. However, those with certain health issues, such as severe hypertension or chronic diseases, will not be able to participate for safety reasons. Participants can expect to engage in the heat therapy for 45 minutes, four times a week, over eight weeks. The study aims to gather information that could eventually lead to new recommendations for managing high blood pressure in older women, making it easier to control and improve their overall health.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women between the ages of 65-85 years with essential hypertension (systolic BP 140-179 and/or diastolic BP 90-109 mmHg)
- • Must be able to understand and speak English
- Exclusion Criteria:
- • Illness or disabilities that preclude home-based heat therapy
- • Any evidence of cardiopulmonary disease
- • Severe hypertension (BP ≥180/110 mmHg; for safety reasons)
- • Secondary hypertension
- • Being on ≥3 antihypertensive agents
- • Chronic kidney disease
- • Diabetes mellitus or other systemic illness
- • Any history of substance abuse (other than tobacco)
- • Current cigarette smokers
- • History of gouty arthritis
- • Taking hormonal replacement therapy
- • Being obese (body mass index ≥30 kg/m2)
- • Endurance trained athletes
- • Impaired cognitive function or diagnosed dementia
About University Of Texas Southwestern Medical Center
The University of Texas Southwestern Medical Center is a leading academic medical institution dedicated to advancing healthcare through innovative research, education, and clinical excellence. With a strong emphasis on translational medicine, the center conducts cutting-edge clinical trials aimed at developing novel therapies and improving patient outcomes across a wide range of diseases. Its multidisciplinary approach leverages a collaborative network of renowned faculty, state-of-the-art facilities, and a commitment to ethical research practices, positioning UT Southwestern at the forefront of medical discovery and patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dallas, Texas, United States
Patients applied
Trial Officials
Qi Fu, MD, PhD
Principal Investigator
University of Texas Southwestern Medical Center
Steven Romero, PhD
Principal Investigator
University of North Texas Health Science Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials